Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy

Autor: Rier, Hánah N., Jager, Agnes, Sleijfer, Stefan, van Rosmalen, Joost, Kock, Marc C.J.M., Levin, Mark-David
Zdroj: In The Breast February 2017 31:9-15
Databáze: ScienceDirect